In recent trading session, Tiziana Life Sciences Ltd (NASDAQ:TLSA) saw 0.52 million shares changing hands at last check today with its beta currently measuring 0.68. Company’s recent per share price level of $0.84 trading at $0.1 or 14.12% at last check today assigns it a market valuation of $92.94M. That most recent trading price of TLSA’s stock is at a discount of -107.14% from its 52-week high price of $1.74 and is indicating a premium of 51.19% from its 52-week low price of $0.41. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.27 million shares which gives us an average trading volume of 322.35K if we extend that period to 3-months.
For Tiziana Life Sciences Ltd (TLSA), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.00. Splitting up the data highlights that, out of 1 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 1 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of 0 in the current quarter.
Tiziana Life Sciences Ltd (NASDAQ:TLSA) trade information
Upright in the green today for gaining 14.12%, in the last five days TLSA remained trading in the green while hitting it’s week-highest on Friday, 01/10/25 when the stock touched $0.84 price level, adding 3.45% to its value on the day. Tiziana Life Sciences Ltd’s shares saw a change of 20.64% in year-to-date performance and have moved 23.37% in past 5-day. Tiziana Life Sciences Ltd (NASDAQ:TLSA) showed a performance of -16.84% in past 30-days. Number of shares sold short was 0.17 million shares which calculate 0.64 days to cover the short interests.
Tiziana Life Sciences Ltd (NASDAQ:TLSA)’s Major holders
ALPHAMARK ADVISORS, LLC is the top institutional holder at TLSA for having 4589.0 shares of worth $0.31 million. And as of 2024-06-30, it was holding 0.0045 of the company’s outstanding shares.
On the other hand, Fidelity NASDAQ Composite Index ETF and Fidelity NASDAQ Composite Index Fund are the top two Mutual Funds which own company’s shares. As of Nov 30, 2024, the former fund manager was holding 164.81 shares of worth $0.14 million or 0.16% of the total outstanding shares. The later fund manager was in possession of 55.88 shares on Nov 30, 2024, making its stake of worth around $47473.0 in the company or a holder of 0.05% of company’s stock.
